News

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...
Table of Contents The Real Story Behind Your Changing Body Making Every Bite Count When You’re Eating Less Your Brain […] The ...
Dr Reddy's reported Rs 1,417 crore net profit in Q1 FY26, driven by new launches and price hikes; firm outlines global ...
"It's criminal to put someone on a GLP-1 and not put them on a dietary plan," says Phil Vella, founder of Vita Bella Health, ...
There’s a perception that Ozempic, Wegovy and Zepbound are all you need to live a healthier life. But diet and exercise still ...
Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...
To increase public access to semaglutide, the UK has begun prescribing Wegovy at no cost to people who meet certain requirements (e.g., BMI over 35). 20 These new prescriptions will add to the ...
A new study suggests that eating more protein while taking GLP-1 medications could help prevent muscle loss, a common side ...
Semaglutide led to a 7.5-point overall improvement (P < .001) for KCCQ-CSS. In patients who did and did not have aFib, the difference in KCCQ-CSS was significant: 11.5 vs 4.3 points, respectively ...